Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 121, Issue , 2014, Pages 354-361

  Hu, Zhengyan ^a,b   Zhang, Hongyan ^a,b   Zhang, Yi ^a,b   Wu, Ren'an ^a   Zou, Hanfa ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Particle size; Protein corona; Quantitative proteomics

Indexed keywords

BIOLOGICAL SYSTEMS; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; NANOPARTICLES; PARTICLE SIZE;

BINDING PROFILES; HUMAN PLASMA PROTEINS; NANOPARTICLE (NPS); NANOPARTICLE SIZES; PROTEIN COMPOSITION; PROTEIN CORONAS; PROTEIN SEPARATIONS; QUANTITATIVE PROTEOMICS; PLASMA PROTEIN;

PROTEINS; PARTICLE SIZE;

PLASMA PROTEIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; IRON OXIDE; NANOPARTICLE; MAGNETITE; PROTEIN BINDING;

ARTICLE; BINDING SITE; BIOCHEMICAL COMPOSITION; CONTROLLED STUDY; MOLECULAR WEIGHT; NANOANALYSIS; PARTICLE SIZE; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN CORONA; PROTEIN DETERMINATION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; PROTEOMICS; QUANTITATIVE ANALYSIS; ZETA POTENTIAL; BIOACCUMULATION; CELL AGGREGATION; CHEMICAL ANALYSIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MATHEMATICAL COMPUTING; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; REVERSED PHASE LIQUID CHROMATOGRAPHY; SYNTHESIS; CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SILVER STAINING; STATIC ELECTRICITY; ULTRASTRUCTURE;

BLOOD PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FERROSOFERRIC OXIDE; HUMANS; NANOPARTICLES; PARTICLE SIZE; PROTEIN BINDING; SILVER STAINING; STATIC ELECTRICITY;

EID: 84905510559     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.06.016     Document Type: Article

References (49)

1. Laurent S., Forge D., Port M., Roch A., Robic C., Elst L.V., Muller R.N. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108:2064-2110.
2. Lines M.G. Nanomaterials for practical functional uses. J. Alloy. Compd. 2008, 449:242-245.
3. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spiccia L. Nanomaterials applications in cancer imaging and therapy. Adv. Mater. 2011, 23:H18-H40.
4. Saunders N.A. Application of nanomaterials to arrays for infectious disease diagnosis. Nanomedicine 2011, 6:271-280.
5. Zhang L., Webster T.J. Nanotechnology and nanomaterials promises for improved tissue regeneration. Nano Today 2009, 4:66-80.
6. Lynch I., Dawson K.A. Protein-nanoparticle interactions. Nano Today 2008, 3:40-47.
7. Walkey C.D., Chan W.C.W. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 2012, 41:2780-2799.
8. Monopoli M.P., Bombelli F.B., Dawson K.A. Nanobiotechnology nanoparticle coronas take shape. Nat. Nanotechnol. 2011, 6:11-12.
9. Lynch I., Salvati A., Dawson K.A. Protein-nanoparticle interactions what does the cell see?. Nat. Nanotechnol. 2009, 4:546-547.
10. Ehrenberg M.S., Friedman A.E., Finkelstein J.N., Oberdorster G., McGrath J.L. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 2009, 30:603-610.
11. Deng Z.J. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 2011, 6:39-44.
12. Hu W., Peng C., Lv M., Li X., Zhang Y., Chen N., Fan C., Huang Q. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 2011, 5:3693-3700.
13. Dutta D., Sundaram S.K., Teeguarden J.G., Riley B.J., Fifield L.S., Jacobs J.M., Addleman S.R., Kaysen G.A., Moudgil B.M., Weber T.J. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 2007, 100:303-315.
14. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 2008, 5:487-495.
15. Lesniak A., Fenaroli F., Monopoli M.R., Aberg C., Dawson K.A., Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012, 6:5845-5857.
16. Vauthier C., Persson B., Lindner P., Cabane B. Protein adsorption and complement activation for di-block copolymer nanoparticles. Biomaterials 2011, 32:1646-1656.
17. Mao H., Chen W., Laurent S., Thirifays C., Burtea C., Rezaee F., Mahmoudi M. Hard corona composition and cellular toxicities of the graphene sheets. Colloid. Surf. B 2013, 109:212-218.
18. Cedervall T., Lynch I., Foy M., Berggård T., Donnelly S.C., Cagney G., Linse S., Dawson K.A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. 2007, 46:5754-5756.
19. Cedervall T., Lynch I., Lindman S., Berggard T., Thulin E., Nilsson H., Dawson K.A., Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. U S A 2007, 104:2050-2055.
20. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., Knauer S.K., Bantz C., Nawroth T., Bier C., Sirirattanapan J., Mann W., Treuel L., Zellner R., Maskos M., Schild H., Stauber R.H. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 2011, 5:7155-7167.
21. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
22. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell sees in bionanoscience. J. Am. Chem. Soc. 2010, 132:5761-5768.
23. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U S A 2008, 105:14265-14270.
24. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134:2139-2147.
25. Deng Z.J., Liang M., Toth I., Monteiro M.J., Minchin R.F. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano 2012, 6:8962-8969.
26. Deng Z.J., Mortimer G., Schiller T., Musumeci A., Martin D., Minchin R.F. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009, 20.
27. Maiorano G., Sabella S., Sorce B., Brunetti V., Malvindi M.A., Cingolani R., Pompa P.P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 2010, 4:7481-7491.
28. Lesniak A., Campbell A., Monopoli M.P., Lynch I., Salvati A., Dawson K.A. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 2010, 31:9511-9518.
29. Caracciolo G., Pozzi D., Capriotti A.L., Cavaliere C., Foglia P., Amenitsch H., Laganà A. Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. Langmuir 2011, 27:15048-15053.
30. Capriotti A.L., Caracciolo G., Cavaliere C., Foglia P., Pozzi D., Samperi R., Laganà A. Do plasma proteins distinguish between liposomes of varying charge density?. J. Proteomics 2012, 75:1924-1932.
31. Gu H.W., Ho P.L., Tsang K.W.T., Wang L., Xu B. Using biofunctional magnetic nanoparticles to capture vancomycin-resistant Enterococci and other gram-positive bacteria at ultralow concentration. J. Am. Chem. Soc. 2003, 125:15702-15703.
32. Bucak S., Jones D.A., Laibinis P.E., Hatton T.A. Protein separations using colloidal magnetic nanoparticles. Biotechnol. Progr. 2003, 19:477-484.
33. Arbab A.S., Yocum G.T., Kalish H., Jordan E.K., Anderson S.A., Khakoo A.Y., Read E.J., Frank J.A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
34. Soenen S.J.H., Himmelreich U., Nuytten N., De Cuyper M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32:195-205.
35. 2 hollow mesoporous spheres as carriers for drug delivery. Small 2010, 6:471-478.
36. Alexiou C., Schmid R.J., Jurgons R., Kremer M., Wanner G., Bergemann C., Huenges E., Nawroth T., Arnold W., Parak F.G. Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur. Biophys. J. 2006, 35:446-450.
37. Mahmoudi M., Shokrgozar M.A., Sardari S., Moghadam M.K., Vali H., Laurent S., Stroeve P. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 2011, 3:1127-1138.
38. Lartigue L., Wilhelm C., Servais J., Factor C., Dencausse A., Bacri J.-C., Luciani N., Gazeau F. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano 2012, 6:2665-2678.
39. Shemetov A.A., Nabiev I., Sukhanova A. Molecular interaction of proteins and peptides with nanoparticles. ACS Nano 2012, 6:4585-4602.
40. Deng H., Li X., Peng Q., Wang X., Chen J., Li Y. Monodisperse magnetic single-crystal ferrite microspheres. Angew. Chem. Int. Ed. 2005, 44:2782-2785.
41. Zhang H., Burnum K.E., Luna M.L., Petritis B.O., Kim J.-S., Qian W.-J., Moore R.J., Heredia-Langner A., Webb-Robertson B.-J.M., Thrall B.D., Camp D.G., Smith R.D., Pounds J.G., Liu T. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics 2011, 11:4569-4577.
42. Klammer A.A., MacCoss M.J. Effects of modified digestion schemes on the identification of proteins from complex mixtures. J. Proteome Res. 2006, 5:695-700.
43. Shilov I.V., Seymour S.L., Patel A.A., Loboda A., Tang W.H., Keating S.P., Hunter C.L., Nuwaysir L.M., Schaeffer D.A. The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 2007, 6:1638-1655.
44. Zeeberg B., Feng W., Wang G., Wang M., Fojo A., Sunshine M., Narasimhan S., Kane D., Reinhold W., Lababidi S., Bussey K., Riss J., Barrett J., Weinstein J. Gominer: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 2003, 4:R28.
45. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., Diemer K., Muruganujan A., Narechania A. Panther: a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13:2129-2141.
46. Lundgren D.H., Hwang S.-I., Wu L., Han D.K. Role of spectral counting in quantitative proteomics. Expert Rev. Proteomics 2010, 7:39-53.
47. Karmali P.P., Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin. Drug Deliv. 2011, 8:343-357.
48. Deng Z.J., Liang M., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 2011, 6:39-44.
49. Prasad R.Y., Wallace K., Daniel K.M., Tennant A.H., Zucker R.M., Strickland J., Dreher K., Kligerman A.D., Blackman C.F., DeMarini D.M. Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS Nano 2013, 7:1929-1942.